Cell-Free Systems Intro: Advantages vs In Vivo TXTL

Added:

The Limitations of Cell-Free TXTL and the Indispensable Advantages of In Vivo Systems

While cell-free transcription-translation (TXTL) systems offer rapid prototyping and bypass cellular toxicity, they possess significant limitations compared to traditional in vivo (living cell) systems. In vivo expression remains the gold standard for producing complex eukaryotic proteins that require intricate post-translational modifications (PTMs), such as glycosylation and disulfide bond formation, which cell-free extracts often fail to replicate accurately. Furthermore, living cells naturally provide specialized chaperones and cellular compartments that facilitate correct protein folding and prevent aggregation. From an economic perspective, cell-free systems are highly expensive and difficult to scale up due to the high cost of preparing active extracts, cofactors, and energy-regeneration substrates. In contrast, living cells self-replicate, making in vivo systems far more cost-effective and scalable for industrial-scale biomanufacturing.

The Central Dogma of Molecular Biology, specifically the mechanisms of transcription and translation (TXTL).
Standard in vivo protein expression methods, including plasmid cloning and the use of host organisms like Escherichia coli.
The basic components of cellular machinery required for protein synthesis, such as ribosomes, tRNAs, RNA polymerase, and energy sources like ATP.
The general limitations of living cellular hosts, such as metabolic burden, cellular toxicity, and membrane barriers.
Protocols for preparing cell-free extracts (lysates) from various organisms like E. coli, wheat germ, and rabbit reticulocytes.
Rapid prototyping of synthetic gene circuits and metabolic pathways using cell-free TXTL platforms.
Applications of cell-free systems in high-throughput protein engineering, screening, and directed evolution.
Incorporation of non-standard or unnatural amino acids (UAAs) into proteins using open-system cell-free platforms.
The development of paper-based cell-free diagnostics and biosensors for point-of-care medical testing.
2.6K views29likes15:34@iGEMFoundationOriginal Release: 2020-09-04

Cell-free transcription and translation (TXTL) systems are laboratory techniques that recreate the central dogma of molecular biology (DNA → RNA → protein) outside living cells by extracting cellular machinery from organisms like E. coli, yeast, or mammalian cells and combining it with necessary compounds in a test tube; this approach offers significant advantages over traditional in vivo methods including faster results, elimination of bacterial transformation steps, ability to express toxic proteins, and reduced biohazard handling, making it ideal for applications such as biomanufacturing, prototyping genetic circuits, diagnostic development, and synthetic biology research.